Resistance to neutralizing antibody and expanded coreceptor usage are associated with human immunodeficiency virus type 1 isolates derived from chimpanzees with pathogenic infectionsJUOMPAN, Laure; JIYPING ZHOU; MONTEFIORI, David C et al.AIDS research and human retroviruses. 2001, Vol 17, Num 18, pp 1705-1714, issn 0889-2229Article

IL-12/GM-CSF coadministration in an SIV DNA prime/protein boost protocol enhances Gag-specific T cells but not virus-specific neutralizing antibodies in rhesus macaquesO'NEILL, Eduardo; BOSTIK, Vanda; MONTEFIORI, David C et al.AIDS research and human retroviruses. 2003, Vol 19, Num 10, pp 883-890, issn 0889-2229, 8 p.Article

Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1PLATT, Emily J; BILSKA, Miroslawa; KOZAK, Susan L et al.Journal of virology. 2009, Vol 83, Num 16, pp 8289-8292, issn 0022-538X, 4 p.Article

Enhanced avidity maturation of antibody to human immunodeficiency virus envelope : DNA vaccination with gpl20-C3d fusion proteinsROSS, Ted M; YAN XU; GREEN, Thomas D et al.AIDS research and human retroviruses. 2001, Vol 17, Num 9, pp 829-835, issn 0889-2229Article

Activity of and Effect of Subcutaneous Treatment with the Broad-Spectrum Antiviral Lectin Griffithsin in Two Laboratory Rodent ModelsBARTON, Christopher; KOUOKAM, J. Calvin; PALMER, Kenneth E et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 120-127, issn 0066-4804, 8 p.Article

High-level, lasting antiviral immunity induced by a bimodal AIDS vaccine and boosted by live-virus exposure: prevention of viremiaRASMUSSEN, Robert A; SIDDAPPA, Nagadenahalli B; O'CONNOR, David et al.AIDS (London). 2012, Vol 26, Num 2, pp 149-155, issn 0269-9370, 7 p.Article

Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and FREVILLA, Ana; DELGADO, Elena; RODRIGUEZ, Raúl et al.AIDS research and human retroviruses. 2011, Vol 27, Num 8, pp 889-901, issn 0889-2229, 13 p.Article

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersLAMBOTTEA, Olivier; FERRARI, Guido; HAYNES, Barton F et al.AIDS (London). 2009, Vol 23, Num 8, pp 897-906, issn 0269-9370, 10 p.Article

Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectorsSANTRA, Sampa; YUE SUN; ERTL, Hildegund C. J et al.Vaccine. 2009, Vol 27, Num 42, pp 5837-5845, issn 0264-410X, 9 p.Article

Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus MonkeysBAROUCH, Dan H; JINYAN LIU; LANDUCCI, Gary et al.Journal of virology. 2009, Vol 83, Num 18, pp 9584-9590, issn 0022-538X, 7 p.Article

Characteristics of effective immune control of simian/human immunodeficiency virus in pigtail macaquesSTRATOV, Ivan; DALE, C. Jane; CHEA, Socheata et al.AIDS research and human retroviruses. 2006, Vol 22, Num 1, pp 27-32, issn 0889-2229, 6 p.Article

An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strainsRAUL GOMEZ-ROMAN, V; FLORESE, Ruth H; BO PENG et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 3, pp 270-277, issn 1525-4135, 8 p.Article

Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern AfricaMING LI; SALAZAR-GONZALEZ, Jesus F; MLISANA, Koleka et al.Journal of virology. 2006, Vol 80, Num 23, pp 11776-11790, issn 0022-538X, 15 p.Article

DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challengeROSATI, Margherita; VON GEGERFELT, Agneta; PAVLAKIS, George N et al.Journal of virology. 2005, Vol 79, Num 13, pp 8480-8492, issn 0022-538X, 13 p.Article

Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteinsMASCOLA, John R; SAMBOR, Anna; YANG, Zhi-Yong et al.Journal of virology. 2005, Vol 79, Num 2, pp 771-779, issn 0022-538X, 9 p.Article

Expanded breadth of virus neutralization after immunization with a multiclade envelope HIV vaccine candidateCHAKRABARTI, Bimal K; XU LING; YANG, Zhi-Yong et al.Vaccine. 2005, Vol 23, Num 26, pp 3434-3445, issn 0264-410X, 12 p.Article

Immunogenicity study of glycoprotein-deficient rabies virus expressing simian/human immunodeficiency virus SHIV_89.6P envelope in a rhesus macaqueMCKENNA, Philip M; PYONE PYONE AYE; DIETZSCHOLD, Bernhard et al.Journal of virology. 2004, Vol 78, Num 24, pp 13455-13459, issn 0022-538X, 5 p.Article

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS vaccine evaluation group protocol 022AGUPTA, Kalpana; HUDGENS, Michael; DOLIN, Raphael et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 29, Num 3, pp 254-261, issn 1525-4135Article

HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal LineagesANTHONY MOODY, M; YATES, Nicole L; YU, Jae-Sung et al.Journal of virology. 2012, Vol 86, Num 14, pp 7496-7507, issn 0022-538X, 12 p.Article

Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy TrialHAYNES, Barton F; GILBERT, Peter B; LIAO, Hua-Xin et al.The New England journal of medicine. 2012, Vol 366, Num 14, pp 1275-1286, issn 0028-4793, 12 p.Article

The Thai Phase III HIV Type 1 Vaccine Trial (RV144) Regimen Induces Antibodies That Target Conserved Regions Within the V2 Loop of gp120KARASAVVAS, Nicos; BILLINGS, Erik; TOMARAS, Georgia D et al.AIDS research and human retroviruses. 2012, Vol 28, Num 11, pp 1444-1457, issn 0889-2229, 14 p.Article

Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: Efficacy against repeated mucosal R5 clade C SHIV challengesLAKHASHE, Samir K; VELU, Vijayakumar; MONTEFIORI, David C et al.Vaccine. 2011, Vol 29, Num 34, pp 5611-5622, issn 0264-410X, 12 p.Article

Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIV_SF162P4ROBINSON, James E; FRANCO, Kelly; HOLTON ELLIOTT, Debra et al.Journal of virology. 2010, Vol 84, Num 7, pp 3443-3453, issn 0022-538X, 11 p.Article

Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing AntibodiesSEAMAN, Michael S; JANES, Holly; BHATTACHARYA, Tanmoy et al.Journal of virology. 2010, Vol 84, Num 3, pp 1439-1452, issn 0022-538X, 14 p.Article

Preclinical Studies of Human Immunodeficiency Virus/AIDS Vaccines : Inverse Correlation between Avidity of Anti-Env Antibodies and Peak Postchallenge ViremiaJUN ZHAO; LILIN LAI; RAO AMARA, Rama et al.Journal of virology. 2009, Vol 83, Num 9, pp 4102-4111, issn 0022-538X, 10 p.Article